Anticancer biangeloyl saponins
US7262285B2 · kind B2 · utility
15Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2005 |
| Grant date | Aug 28, 2007 |
| Priority date | — |
| Expiry date | Aug 16, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J63/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds such as compounds designated herein as Xanifolia-Y or -Y3, -Y1, -Y2, -Y8, -Y9 and -Y10 are disclosed. These compounds have anticancer activity. The compounds of the present invention are obtainable from plants in the sapindaceae family, such as Xanthoceras sorbifolia, or other natural sources or products. The compounds of the present invention may also be synthesized chemically
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.